Selskabets formål er at forestå integreret produktudvikling og/eller produktion af medicoteknisk udstyr og hermed beslægtet virksomhed efter bestyrelsens skøn.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 425.6 mio. | 12.1 mio. | 242.3 mio. | 113.5 mio. | - | |
CVR: 24053415
Secondary names: Medicom Innovation Partner a/s
Previous names: BANG & OLUFSEN EXPORT A/S, BANG & OLUFSEN TECHNOLOGY A/S, BANG & OLUFSEN MEDICOM A/S
1 properties
Upgrade to Pro to see addresses, building data and ownership details
Nitesh Gupta joined the board
Sean David Rice left the board
Compared to 297 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
The financial health of Phillips-Medisize A/S shows signs of volatility, with a notable decline in both revenue and profit from 2023 to 2024. Revenue decreased from 481.9 million DKK to 425.6 million DKK, while profit fell sharply from 83.4 million DKK to 12.1 million DKK. Despite this downturn, the company has demonstrated growth in previous years, with revenue increasing from 274.6 million DKK in 2020 to a peak of 481.9 million DKK in 2023. However, the significant drop in equity from 241.4 million DKK to 113.5 million DKK raises concerns about financial stability and operational efficiency. Positioned within the medical and dental instrument manufacturing sector, the company may need to address these challenges to maintain its competitive edge.
AI-generated summary
Companies in the same industry and area
companydata.dk